Cartesian Therapeutics, Inc. (RNAC): Nasdaq/NYSE listing notice — Cartesian Therapeutics receives Nasdaq notice of non-compliance with minimum bid price requirement

Cartesian Therapeutics, Inc.

Nasdaq notified Cartesian on Jan 17, 2024 that its common stock closing bid price fell below $1.00 for 30 consecutive business days.
Company has until July 15, 2024 to regain compliance; must close at or above $1.00 for 10 consecutive business days.
If not compliant by July 15, may qualify for additional 180-day period by transferring to Nasdaq Capital Market and meeting other standards.
Cartesian intends to monitor bid price and consider available options; no assurance of regaining compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cartesian Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

January 17, 2024, Cartesian Therapeutics, Inc. (the “Company”) received a notice from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock, par value $0.0001 per share (the “Common Stock”), has fallen below $1.00 per share for 30 consecutive business days, the Company no longer meets the minimum bid price requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5450(a)(1). The notification from Nasdaq has no immediate effect on the listing of the Company’s Common S

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Cartesian Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001453687-24-000030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.